Patents by Inventor Cellectis

Cellectis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130209437
    Abstract: A method for engineering I-CreI homing endonuclease variants able to cleave mutant I-CreI sites having variation in positions ±8 to ±10. A I-CreI homing endonuclease variant obtainable by said method, a vector encoding said variant, a cell, an animal or a plant modified by said vector. Use of said I-CreI endonuclease variant and derived products for genetic engineering, genome therapy and antiviral therapy.
    Type: Application
    Filed: January 17, 2013
    Publication date: August 15, 2013
    Applicant: CELLECTIS
    Inventor: Cellectis
  • Publication number: 20130203840
    Abstract: A single chain homing endonuclease, comprising a first variant of I-CreI having the amino acid sequence of accession number pdb 1g9y and a second variant of I-CreI variant having the amino acid sequence of accession number pdb 1g9y in a single polypeptide.
    Type: Application
    Filed: October 10, 2012
    Publication date: August 8, 2013
    Applicant: CELLECTIS S.A.
    Inventor: Cellectis S.A.
  • Publication number: 20130137644
    Abstract: The invention provides cell penetrating peptide-nucleic acid conjugates having the formula P-L-N, wherein P is a cell penetrating peptide, N is a nucleic acid, preferably an oligonucleotide and more preferably a siRNA, and L is a hydrophilic polymer, preferably a polyethylene glycol (PEG)-based linker linking P and N together. Compositions, methods of use and methods for producing such conjugates are also disclosed.
    Type: Application
    Filed: October 24, 2012
    Publication date: May 30, 2013
    Applicant: Cellectis
    Inventor: Cellectis